Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Immunology|July 30, 2026
Emerging Principles in Spatial Functional GenomicsAlexander Tepper, Trung Nguyen, Chiara Falcomatà, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Plasminogen activator inhibitors orchestrate the immunosuppressive tumor microenvironment in pancreatic cancerChiara Falcomatà, Sebastian R Nielsen, Maximilian M Schaefer, et al.
Leukemia|December 20, 2023
Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7Michael C Kann, Emily M Schneider, Antonio J Almazan, et al.
Stem Cells and Development|January 21, 2017
Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous LeukemiaAnna Chorzalska, Javier Flores Kim, Karim Roder, et al.
Molecular Oncology|February 28, 2018
Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemiaAnna Chorzalska, Nagib Ahsan, R Shyama Prasad Rao, et al.
Cell|October 31, 2024
Ovarian cancer-derived IL-4 promotes immunotherapy resistanceGurkan Mollaoglu, Alexander Tepper, Chiara Falcomatà, et al.
Cancer Cell|January 23, 2026
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growthJaime Mateus-Tique, Ashwitha Lakshmi, Bhavya Singh, et al.
Science Translational Medicine|January 7, 2021
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomideMax Jan, Irene Scarfò, Rebecca C Larson, et al.
Blood Cancer Discovery|May 24, 2021
Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignanciesAline Renneville, Jessica A Gasser, Daniel E Grinshpun, et al.
Blood|September 15, 2018
Bone marrow-specific loss ofAnna Chorzalska, John Morgan, Nagib Ahsan, et al.
Pageof 2